Pim-1/2 kinase inhibitor 1
CAS No. 6320-51-0
Pim-1/2 kinase inhibitor 1( —— )
Catalog No. M37616 CAS No. 6320-51-0
Pim-1/2 Kinase Inhibitor 1, an orally active inhibitor, impedes the action of Pim kinases by preventing their ability to phosphorylate peptides.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 30 | In Stock |
|
| 10MG | 50 | In Stock |
|
| 25MG | 102 | In Stock |
|
| 50MG | 155 | In Stock |
|
| 100MG | 233 | In Stock |
|
| 200MG | 319 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePim-1/2 kinase inhibitor 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPim-1/2 Kinase Inhibitor 1, an orally active inhibitor, impedes the action of Pim kinases by preventing their ability to phosphorylate peptides.
-
DescriptionPim-1/2 kinase inhibitor 1 is an orally active pim-1/2 kinase inhibitor. Pim-1/2 kinase inhibitor 1 blocks the ability of Pim kinases to phosphorylate peptides, and inhibits the pim protein kinase directed phosphorylation of 4E-BP1 and p27Kip1. Pim-1/2 kinase inhibitor 1 can be used in study of cancer, especially prostate cancer.
-
In VitroPim-1/2 kinase inhibitor 1 (compound D14) (varying concentrations; 48 h) shows cytotoxicity to PC3 cells, with an IC of 11 μM.Cell Cytotoxicity Assay Cell Line:PC3 cells Concentration:varying concentrations Incubation Time:48 h Result:Inhibited PC3 cells with an IC of 11 μM.
-
In Vivo——
-
Synonyms——
-
PathwayJAK/STAT Signaling
-
TargetPim
-
RecptorPim
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6320-51-0
-
Formula Weight235.26
-
Molecular FormulaC11H9NO3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (1062.65 mM; Ultrasonic (<60°C)
-
SMILESCOc1ccc(C=C2SC(=O)NC2=O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Charles D. Smith, et al. Inhibitors of PIM-1 Protein Kinases, Compositions and Methods for Treating Prostate Cancer. Patent US20110263664A1.
molnova catalog
related products
-
SGI-1776
SGI-1776 is a potent, selective, orally active Pim kinase inhibitor with IC50 of 7, 363 and 69 nM for Pim1, Pim2 and Pim3, respectively.
-
Taprenepag
Taprenepag (CP-544326) is a potent and selective prostaglandin E2 receptor agonist (EC50 = 2.8 nM).
-
VS-II-173
VS-II-173 is a highly potent Pim1 and Pim3 inhibitor with IC50 of 70 and 20 nM respectively.
Cart
sales@molnova.com